ALUMINIUM AND DIALYSIS BONE-DISEASE
Authors:
- G Cournot-WitmerGCG Cournot-Witmer
- J ZingraffJZJ Zingraff
- R BourdonRBR Bourdon
- T DrüekeTDT Drüeke
- S BalsanSBS Balsan
- 1 October 1979
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 314 (8146) , 795-796
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Growth Hormone Secretion in Hypertensive Patients: Evidence for a Derangement in Central Adrenergic FunctionClinical Science, 1980
- FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHYThe Lancet, 1979
- OSTEOMALACIC DIALYSIS OSTEODYSTROPHY: EVIDENCE FOR A WATER-BORNE ÆTIOLOGICAL AGENT, PROBABLY ALUMINIUMThe Lancet, 1978
- Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.BMJ, 1977
- Effect of antihypertensive drugs on growth hormone secretion.BMJ, 1977
- Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failureKidney International, 1976
- The Dialysis Encephalopathy SyndromeNew England Journal of Medicine, 1976
- Aluminium in Bone from Patients with Renal FailureBMJ, 1971